Many clinics turned to compounded versions of semaglutide during the shortage to maintain patient care
Evidence from TRIUMPH-4 and TRIUMPH-1: Mostly rated as "mild" by participants Rarely led to discontinuation (12%) No progression to serious neurological issues Reversible when medication stopped (in Phase 2 extension) When to Call Your Doctor About Dysesthesia Call if you experience: Severe pain (not just tingling) Progressive worsening despite dose stability Loss of coordination or balance Weakness in hands or feet Symptoms interfering with daily life Likely benign if: Mild tingling only Stable or improving over time No pain or weakness Managing Nausea: The Most Common Side Effect Why GLP-1 Medications Cause Nausea GLP-1 slows gastric emptying food stays in stomach longer Longer gastric residence feeling of fullness (desired!) or nausea (not desired) Brain signaling changes nausea sensation Good news: This is the SAME mechanism producing weight loss
Naming confusion: FDA described inconsistent naming around no-DAC, DAC, free-base, and salt forms
Why Understanding the Microdosing Chart Matters Microdosing charts may look simple, but they require close attention to: The dose amount (mg) The week number The frequency (usually weekly) The concentration of the vial or pen Because doses are small and adjustments occur more frequently, misreading a chart can lead to: Underdosing, which may delay results Overdosing, which may cause nausea, fatigue, constipation, or dizziness Skipping increments, which can overwhelm the GI system Microdosing works because it is gradual and preciseso interpreting the chart correctly is essential
